We spoke to Dr. Marisa Spann about her work in early childhood psychiatry, her new role in the Office of Equity, Diversity and Inclusion, and having honest, direct conversations about race.
In November 2021, Columbia Psychiatry stepped up as a leader in this field and named Elizabeth Ford, MD, to the newly created position of Director of Mental Health and Criminal Justice Initiatives.
The Center for Practice Innovations is New York’s secret asset quietly helping to make the state’s 38,000 public sector behavioral health workforce among the best trained in the country.
An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects.
"The evidence overwhelmingly suggests that the majority of patients with schizophrenia benefit from antipsychotic treatment, says Dr. Jeffrey Lieberman.
This discussion is on the under-recognized and often crippling effects anxiety can have on young people and what NewYork-Presbyterian Youth Anxiety Center is doing about it.
“Murphy has been the most outspoken critic—rightly so—of SAMHSA, and Ellie quit SAMHSA for much of the same reasons. There’s something here that doesn’t add up,” said Dr. Jeffrey Lieberman.
“Ketamine, as a treatment, is often paired with the experience or during consolidation of memories or some type of arousal related to the experience,” said Dr. Christine Denny.
“It’s a drug that seems to act at a wide range of brain sites so in terms of anxiety, one of its potential mechanisms could be acting at one of the serotonin receptors," said Dr. Margaret Haney.